Compare TMUS & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMUS | ABT |
|---|---|---|
| Founded | 1994 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.3B | 222.8B |
| IPO Year | N/A | N/A |
| Metric | TMUS | ABT |
|---|---|---|
| Price | $210.06 | $124.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 18 |
| Target Price | ★ $270.57 | $146.61 |
| AVG Volume (30 Days) | 4.7M | ★ 6.4M |
| Earning Date | 10-23-2025 | 01-21-2026 |
| Dividend Yield | ★ 1.95% | 1.89% |
| EPS Growth | 18.54 | ★ 141.97 |
| EPS | ★ 10.38 | 7.96 |
| Revenue | ★ $85,847,000,000.00 | $43,843,000,000.00 |
| Revenue This Year | $10.53 | $7.56 |
| Revenue Next Year | $7.36 | $7.96 |
| P/E Ratio | $20.19 | ★ $15.71 |
| Revenue Growth | ★ 7.30 | 6.37 |
| 52 Week Low | $199.41 | $110.86 |
| 52 Week High | $276.49 | $141.23 |
| Indicator | TMUS | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 45.35 | 41.37 |
| Support Level | $206.71 | $124.06 |
| Resistance Level | $211.81 | $129.85 |
| Average True Range (ATR) | 3.62 | 2.81 |
| MACD | 0.62 | -0.21 |
| Stochastic Oscillator | 31.85 | 27.79 |
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves 85 million postpaid and 26 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves 7 million residential and business customers with its wireless network. It also serves nearly 1 million fiber broadband customers through joint ventures with fiber network owners. T-Mobile owns a stake in these firms, which provide wholesale access to their networks. In addition, T-Mobile provides wholesale services to wireless resellers.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.